DOLOBID Trademark

Trademark Overview


On Monday, October 14, 2019, a trademark application was filed for DOLOBID with the United States Patent and Trademark Office. The USPTO has given the DOLOBID trademark a serial number of 88653249. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 22, 2023. This trademark is owned by Athena Bioscience, LLC. The DOLOBID trademark is filed in the Pharmaceutical Products category with the following description:

Pain relief medication
dolobid

General Information


Serial Number88653249
Word MarkDOLOBID
Filing DateMonday, October 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 22, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements


Goods and ServicesPain relief medication

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAthena Bioscience, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWatkinsville, GA 30677

Party NameAthena Bioscience, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAthens, GA 30601

Trademark Events


Event DateEvent Description
Monday, May 22, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 22, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 24, 2022SOU EXTENSION 5 GRANTED
Thursday, October 20, 2022SOU EXTENSION 5 FILED
Thursday, October 20, 2022TEAS EXTENSION RECEIVED
Thursday, April 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2022SOU EXTENSION 4 GRANTED
Tuesday, April 19, 2022SOU EXTENSION 4 FILED
Tuesday, April 19, 2022TEAS EXTENSION RECEIVED
Friday, October 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 20, 2021SOU EXTENSION 3 GRANTED
Wednesday, October 20, 2021SOU EXTENSION 3 FILED
Wednesday, October 20, 2021TEAS EXTENSION RECEIVED
Thursday, April 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 20, 2021SOU EXTENSION 2 GRANTED
Tuesday, April 20, 2021SOU EXTENSION 2 FILED
Tuesday, April 20, 2021TEAS EXTENSION RECEIVED
Tuesday, April 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021SOU EXTENSION 1 GRANTED
Wednesday, October 21, 2020SOU EXTENSION 1 FILED
Tuesday, February 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 9, 2020NOTICE OF REVIVAL - E-MAILED
Monday, November 9, 2020EXTENSION RECEIVED WITH TEAS PETITION
Monday, November 9, 2020PETITION TO REVIVE-GRANTED
Monday, November 9, 2020TEAS PETITION TO REVIVE RECEIVED
Tuesday, April 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, January 19, 2020ASSIGNED TO EXAMINER
Friday, October 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 17, 2019NEW APPLICATION ENTERED

Related Keywords


dolobid medication relief pain